25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

8EM (Editas Medicine Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Editas Medicine Inc together

I guess you are interested in Editas Medicine Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Editas Medicine Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Editas Medicine Inc’s Price Targets

I'm going to help you getting a better view of Editas Medicine Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Editas Medicine Inc

I send you an email if I find something interesting about Editas Medicine Inc.

1. Quick Overview

1.1. Quick analysis of Editas Medicine Inc (30 sec.)










1.2. What can you expect buying and holding a share of Editas Medicine Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€1.96
Expected worth in 1 year
€-0.15
How sure are you?
15.4%

+ What do you gain per year?

Total Gains per Share
€-2.11
Return On Investment
-158.6%

For what price can you sell your share?

Current Price per Share
€1.33
Expected price per share
€1.1 - €3.095
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Editas Medicine Inc (5 min.)




Live pricePrice per Share (EOD)
€1.33
Intrinsic Value Per Share
€-17.91 - €-20.63
Total Value Per Share
€-15.95 - €-18.67

2.2. Growth of Editas Medicine Inc (5 min.)




Is Editas Medicine Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$175.6m$359.6m-$96.8m-36.9%

How much money is Editas Medicine Inc making?

Current yearPrevious yearGrowGrow %
Making money-$52.6m-$48.7m-$3.8m-7.4%
Net Profit Margin-30,134.7%-916.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Editas Medicine Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Editas Medicine Inc?

Welcome investor! Editas Medicine Inc's management wants to use your money to grow the business. In return you get a share of Editas Medicine Inc.

First you should know what it really means to hold a share of Editas Medicine Inc. And how you can make/lose money.

Speculation

The Price per Share of Editas Medicine Inc is €1.328. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Editas Medicine Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Editas Medicine Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €1.96. Based on the TTM, the Book Value Change Per Share is €-0.53 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.37 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Editas Medicine Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps-0.75-56.7%-0.64-48.1%-0.66-49.7%-0.67-50.4%-0.67-50.4%
Usd Book Value Change Per Share-0.69-51.7%-0.57-43.0%-0.40-30.5%0.1612.3%0.1612.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.69-51.7%-0.57-43.0%-0.40-30.5%0.1612.3%0.1612.3%
Usd Price Per Share3.28-6.35-7.78-12.71-12.71-
Price to Earnings Ratio-1.09--3.96--3.07--5.39--5.39-
Price-to-Total Gains Ratio-4.78--22.78--2.50--16.61--16.61-
Price to Book Ratio1.54-1.91-1.62-2.18-2.18-
Price-to-Total Gains Ratio-4.78--22.78--2.50--16.61--16.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.441544
Number of shares693
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.570.16
Usd Total Gains Per Share-0.570.16
Gains per Quarter (693 shares)-396.00113.43
Gains per Year (693 shares)-1,584.00453.72
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1584-15940454444
20-3168-31780907898
30-4752-4762013611352
40-6336-6346018151806
50-7920-7930022692260
60-9504-9514027222714
70-11088-11098031763168
80-12672-12682036303622
90-14256-14266040834076
100-15840-15850045374530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%2.011.00.015.4%2.011.00.015.4%2.011.00.015.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%2.011.00.015.4%2.011.00.015.4%2.011.00.015.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Editas Medicine Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.633-0.526-17%-0.373-41%0.151-520%0.151-520%
Book Value Per Share--1.9602.946-33%4.411-56%4.883-60%4.883-60%
Current Ratio--3.7474.397-15%6.455-42%7.827-52%7.827-52%
Debt To Asset Ratio--0.4640.373+24%0.291+60%0.278+67%0.278+67%
Debt To Equity Ratio--0.8650.612+41%0.411+111%0.406+113%0.406+113%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--109718658.000342151696.608-68%403018042.890-73%714836536.036-85%714836536.036-85%
Eps---0.694-0.589-15%-0.607-12%-0.616-11%-0.616-11%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--488.131177.156+176%22.747+2046%448.231+9%448.231+9%
Free Cash Flow Per Share---0.620-0.535-14%-0.483-22%-0.540-13%-0.540-13%
Free Cash Flow To Equity Per Share---0.620-0.532-14%-0.149-76%-0.432-30%-0.432-30%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---20.631--------
Intrinsic Value_10Y_min---17.906--------
Intrinsic Value_1Y_max---2.136--------
Intrinsic Value_1Y_min---2.099--------
Intrinsic Value_3Y_max---6.367--------
Intrinsic Value_3Y_min---6.079--------
Intrinsic Value_5Y_max---10.533--------
Intrinsic Value_5Y_min---9.781--------
Market Cap--249679337.600480499355.008-48%538088301.990-54%841206893.759-70%841206893.759-70%
Net Profit Margin---1018.705-301.347-70%-9.166-99%-199.566-80%-199.566-80%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1077.492320.019+237%10.889+9796%209.527+414%209.527+414%
Pb Ratio0.677-128%1.5431.908-19%1.622-5%2.180-29%2.180-29%
Pe Ratio-0.479+56%-1.090-3.959+263%-3.073+182%-5.386+394%-5.386+394%
Price Per Share1.328-128%3.0255.851-48%7.169-58%11.711-74%11.711-74%
Price To Free Cash Flow Ratio-0.536+56%-1.221-3.615+196%-3.741+206%-5.612+360%-5.612+360%
Price To Total Gains Ratio-2.099+56%-4.782-22.785+377%-2.495-48%-16.610+247%-16.610+247%
Quick Ratio--2.3412.992-22%3.823-39%4.601-49%4.601-49%
Return On Assets---0.190-0.136-28%-0.097-49%-0.102-46%-0.102-46%
Return On Equity---0.354-0.227-36%-0.137-61%-0.150-58%-0.150-58%
Total Gains Per Share---0.633-0.526-17%-0.373-41%0.151-520%0.151-520%
Usd Book Value--175627431.288262775171.841-33%359619549.726-51%386372241.445-55%386372241.445-55%
Usd Book Value Change Per Share---0.687-0.571-17%-0.404-41%0.164-520%0.164-520%
Usd Book Value Per Share--2.1283.198-33%4.788-56%5.300-60%5.300-60%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--119099603.259371405666.668-68%437476085.557-73%775955059.867-85%775955059.867-85%
Usd Eps---0.753-0.639-15%-0.659-12%-0.669-11%-0.669-11%
Usd Free Cash Flow---55506923.963-47836960.831-14%-39060289.091-30%-43592831.106-21%-43592831.106-21%
Usd Free Cash Flow Per Share---0.672-0.581-14%-0.524-22%-0.586-13%-0.586-13%
Usd Free Cash Flow To Equity Per Share---0.672-0.578-14%-0.162-76%-0.469-30%-0.469-30%
Usd Market Cap--271026920.965521582049.861-48%584094851.810-54%913130083.175-70%913130083.175-70%
Usd Price Per Share1.442-128%3.2846.351-48%7.782-58%12.713-74%12.713-74%
Usd Profit---62138675.927-52641031.152-15%-48768925.974-22%-49680218.813-20%-49680218.813-20%
Usd Revenue--60997.71915438922.563-100%6152269.897-99%9092659.922-99%9092659.922-99%
Usd Total Gains Per Share---0.687-0.571-17%-0.404-41%0.164-520%0.164-520%
 EOD+3 -3MRQTTM+4 -31YOY+3 -325Y+4 -3110Y+4 -31

3.3 Fundamental Score

Let's check the fundamental score of Editas Medicine Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.479
Price to Book Ratio (EOD)Between0-10.677
Net Profit Margin (MRQ)Greater than0-1,018.705
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.341
Current Ratio (MRQ)Greater than13.747
Debt to Asset Ratio (MRQ)Less than10.464
Debt to Equity Ratio (MRQ)Less than10.865
Return on Equity (MRQ)Greater than0.15-0.354
Return on Assets (MRQ)Greater than0.05-0.190
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Editas Medicine Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.240
Ma 20Greater thanMa 501.657
Ma 50Greater thanMa 1001.402
Ma 100Greater thanMa 2001.813
OpenGreater thanClose1.234
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Editas Medicine Inc

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Editas Medicine Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Editas Medicine Inc to theΒ  industry mean.
  • A Net Profit Margin of -101,870.5%Β means thatΒ €-1,018.70 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Editas Medicine Inc:

  • The MRQ is -101,870.5%. The company is making a huge loss. -2
  • The TTM is -30,134.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-101,870.5%TTM-30,134.7%-71,735.8%
TTM-30,134.7%YOY-916.6%-29,218.1%
TTM-30,134.7%5Y-19,956.6%-10,178.1%
5Y-19,956.6%10Y-19,956.6%0.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Editas Medicine Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Editas Medicine Inc to theΒ  industry mean.
  • -19.0% Return on Assets means thatΒ Editas Medicine Inc generatedΒ €-0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Editas Medicine Inc:

  • The MRQ is -19.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.0%TTM-13.6%-5.4%
TTM-13.6%YOY-9.7%-3.9%
TTM-13.6%5Y-10.2%-3.4%
5Y-10.2%10Y-10.2%0.0%
4.3.1.3. Return on Equity

Shows how efficient Editas Medicine Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Editas Medicine Inc to theΒ  industry mean.
  • -35.4% Return on Equity means Editas Medicine Inc generated €-0.35Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Editas Medicine Inc:

  • The MRQ is -35.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -22.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-35.4%TTM-22.7%-12.6%
TTM-22.7%YOY-13.7%-9.0%
TTM-22.7%5Y-15.0%-7.8%
5Y-15.0%10Y-15.0%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Editas Medicine Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Editas Medicine Inc is operatingΒ .

  • Measures how much profit Editas Medicine Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Editas Medicine Inc to theΒ  industry mean.
  • An Operating Margin of 0.0%Β means the company generated €0.00 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Editas Medicine Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Editas Medicine Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ  industry mean).
  • An Operation Ratio of 1,077.49 means that the operating costs are €1,077.49 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Editas Medicine Inc:

  • The MRQ is 1,077.492. The company is inefficient in keeping operating costs low. -1
  • The TTM is 320.019. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1,077.492TTM320.019+757.473
TTM320.019YOY10.889+309.130
TTM320.0195Y209.527+110.492
5Y209.52710Y209.5270.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Editas Medicine Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Editas Medicine Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ  industry mean).
  • A Current Ratio of 3.75Β means the company has €3.75 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Editas Medicine Inc:

  • The MRQ is 3.747. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.397. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.747TTM4.397-0.650
TTM4.397YOY6.455-2.058
TTM4.3975Y7.827-3.430
5Y7.82710Y7.8270.000
4.4.3.2. Quick Ratio

Measures if Editas Medicine Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Editas Medicine Inc to theΒ  industry mean.
  • A Quick Ratio of 2.34Β means the company can pay off €2.34 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Editas Medicine Inc:

  • The MRQ is 2.341. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.992. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.341TTM2.992-0.651
TTM2.992YOY3.823-0.831
TTM2.9925Y4.601-1.610
5Y4.60110Y4.6010.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Editas Medicine Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Editas Medicine IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Editas Medicine Inc to industry mean.
  • A Debt to Asset Ratio of 0.46Β means that Editas Medicine Inc assets areΒ financed with 46.4% credit (debt) and the remaining percentage (100% - 46.4%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Editas Medicine Inc:

  • The MRQ is 0.464. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.373. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.464TTM0.373+0.091
TTM0.373YOY0.291+0.083
TTM0.3735Y0.278+0.095
5Y0.27810Y0.2780.000
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Editas Medicine Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Editas Medicine Inc to theΒ  industry mean.
  • A Debt to Equity ratio of 86.5% means that company has €0.87 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Editas Medicine Inc:

  • The MRQ is 0.865. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.612. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.865TTM0.612+0.253
TTM0.612YOY0.411+0.202
TTM0.6125Y0.406+0.206
5Y0.40610Y0.4060.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Editas Medicine Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Editas Medicine Inc to theΒ  industry mean.
  • A PE ratio of -1.09 means the investor is paying €-1.09Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Editas Medicine Inc:

  • The EOD is -0.479. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.090. Based on the earnings, the company is expensive. -2
  • The TTM is -3.959. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.479MRQ-1.090+0.612
MRQ-1.090TTM-3.959+2.869
TTM-3.959YOY-3.073-0.886
TTM-3.9595Y-5.386+1.427
5Y-5.38610Y-5.3860.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Editas Medicine Inc:

  • The EOD is -0.536. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.221. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.615. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.536MRQ-1.221+0.685
MRQ-1.221TTM-3.615+2.394
TTM-3.615YOY-3.741+0.126
TTM-3.6155Y-5.612+1.997
5Y-5.61210Y-5.6120.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Editas Medicine Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to industry mean).
  • A PB ratio of 1.54 means the investor is paying €1.54Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Editas Medicine Inc:

  • The EOD is 0.677. Based on the equity, the company is cheap. +2
  • The MRQ is 1.543. Based on the equity, the company is underpriced. +1
  • The TTM is 1.908. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.677MRQ1.543-0.866
MRQ1.543TTM1.908-0.365
TTM1.908YOY1.622+0.287
TTM1.9085Y2.180-0.272
5Y2.18010Y2.1800.000
4.6.2. Total Gains per Share

2.4. Latest News of Editas Medicine Inc

Does Editas Medicine Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Editas Medicine Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-03-13
11:56
Here's Why Editas Medicine (NASDAQ:EDIT) Must Use Its Cash WiselyRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets327,567
Total Liabilities151,933
Total Stockholder Equity175,634
 As reported
Total Liabilities 151,933
Total Stockholder Equity+ 175,634
Total Assets = 327,567

Assets

Total Assets327,567
Total Current Assets271,139
Long-term Assets56,428
Total Current Assets
Cash And Cash Equivalents 95,832
Short-term Investments 169,256
Net Receivables 126
Other Current Assets 5,925
Total Current Assets  (as reported)271,139
Total Current Assets  (calculated)271,139
+/-0
Long-term Assets
Property Plant Equipment 51,147
Long-term Assets Other 5,281
Long-term Assets  (as reported)56,428
Long-term Assets  (calculated)56,428
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities72,353
Long-term Liabilities79,580
Total Stockholder Equity175,634
Total Current Liabilities
Accounts payable 12,491
Total Current Liabilities  (as reported)72,353
Total Current Liabilities  (calculated)12,491
+/- 59,862
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt38,488
Long-term Liabilities Other 3,281
Long-term Liabilities  (as reported)79,580
Long-term Liabilities  (calculated)41,769
+/- 37,811
Total Stockholder Equity
Total Stockholder Equity (as reported)175,634
Total Stockholder Equity (calculated)0
+/- 175,634
Other
Capital Stock8
Common Stock Shares Outstanding 82,539
Net Invested Capital 175,634
Net Working Capital 198,786
Property Plant and Equipment Gross 81,677



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-30
> Total Assets 
717,019
677,483
623,108
580,833
531,029
514,321
464,105
541,953
504,650
499,153
440,347
384,801
327,567
327,567384,801440,347499,153504,650541,953464,105514,321531,029580,833623,108677,483717,019
   > Total Current Assets 
567,608
507,310
497,031
461,377
426,629
356,754
324,458
440,978
358,603
340,829
305,555
286,354
271,139
271,139286,354305,555340,829358,603440,978324,458356,754426,629461,377497,031507,310567,608
       Cash And Cash Equivalents 
259,884
203,519
210,881
169,401
210,704
141,522
129,021
220,817
82,537
123,652
69,227
64,441
95,832
95,83264,44169,227123,65282,537220,817129,021141,522210,704169,401210,881203,519259,884
       Short-term Investments 
297,957
296,326
277,481
283,157
208,913
202,752
189,418
211,151
267,080
199,459
226,944
214,671
169,256
169,256214,671226,944199,459267,080211,151189,418202,752208,913283,157277,481296,326297,957
       Net Receivables 
251
267
1,371
713
120
5,145
242
2,286
2,422
10,187
245
244
126
12624424510,1872,4222,2862425,1451207131,371267251
       Other Current Assets 
0
0
7,298
8,106
6,892
7,335
5,777
6,724
6,564
7,531
9,139
6,998
5,925
5,9256,9989,1397,5316,5646,7245,7777,3356,8928,1067,29800
   > Long-term Assets 
149,411
170,173
126,077
119,456
104,400
157,567
139,647
100,975
146,047
158,324
134,792
98,447
56,428
56,42898,447134,792158,324146,047100,975139,647157,567104,400119,456126,077170,173149,411
       Property Plant Equipment 
0
0
0
0
38,026
59,217
49,555
47,657
43,495
45,712
44,700
51,107
51,147
51,14751,10744,70045,71243,49547,65749,55559,21738,0260000
       Long Term Investments 
99,198
120,071
78,046
75,062
58,844
93,097
83,339
48,065
96,797
104,024
80,605
39,195
0
039,19580,605104,02496,79748,06583,33993,09758,84475,06278,046120,07199,198
       Long-term Assets Other 
6,781
6,811
7,316
7,530
7,530
5,253
6,753
5,253
5,755
8,588
9,487
8,145
5,281
5,2818,1459,4878,5885,7555,2536,7535,2537,5307,5307,3166,8116,781
> Total Liabilities 
130,225
123,841
110,348
115,419
116,284
153,641
146,632
142,036
144,188
150,056
145,947
152,792
151,933
151,933152,792145,947150,056144,188142,036146,632153,641116,284115,419110,348123,841130,225
   > Total Current Liabilities 
50,907
46,884
36,503
36,421
42,289
60,110
57,155
54,513
58,603
63,217
66,487
74,306
72,353
72,35374,30666,48763,21758,60354,51357,15560,11042,28936,42136,50346,88450,907
       Accounts payable 
3,402
5,050
4,693
6,169
6,836
9,511
9,047
8,066
10,411
8,269
7,966
13,769
12,491
12,49113,7697,9668,26910,4118,0669,0479,5116,8366,1694,6935,0503,402
   > Long-term Liabilities 
79,318
76,957
73,845
78,998
73,995
93,531
89,477
87,523
85,585
86,839
79,460
78,486
79,580
79,58078,48679,46086,83985,58587,52389,47793,53173,99578,99873,84576,95779,318
       Capital Lease Obligations Min Short Term Debt
28,693
26,378
23,163
20,257
21,301
43,946
37,137
37,186
34,611
36,536
34,139
38,698
38,488
38,48838,69834,13936,53634,61137,18637,13743,94621,30120,25723,16326,37828,693
> Total Stockholder Equity
586,794
553,642
512,760
465,414
414,745
360,680
317,473
399,917
360,462
349,097
294,400
232,009
175,634
175,634232,009294,400349,097360,462399,917317,473360,680414,745465,414512,760553,642586,794
   Common Stock0000000000000
   Retained Earnings Total Equity0000000000000
   Accumulated Other Comprehensive Income 0000000000000
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 0000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue78,123
Cost of Revenue--
Gross Profit-78,123
 
Operating Income (+$)
Gross Profit-
Operating Expense-247,304
Operating Income-169,181-247,304
 
Operating Expense (+$)
Research Development177,651
Selling General Administrative69,653
Selling And Marketing Expenses-
Operating Expense247,304247,304
 
Net Interest Income (+$)
Interest Income17,566
Interest Expense--
Other Finance Cost-0
Net Interest Income17,566
 
Pretax Income (+$)
Operating Income-169,181
Net Interest Income17,566
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-153,219-167,577
EBIT - interestExpense = 0
-153,219
-153,219
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--153,219
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-153,219
Tax Provision--
Net Income From Continuing Ops-153,219-153,219
Net Income-153,219
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,604-17,566
 

Technical Analysis of Editas Medicine Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Editas Medicine Inc. The general trend of Editas Medicine Inc is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Editas Medicine Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Editas Medicine Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Editas Medicine Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.59 < 2.944 < 3.095.

The bearish price targets are: 1.1 > 1.1.

Tweet this
Editas Medicine Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Editas Medicine Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Editas Medicine Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Editas Medicine Inc. The current macd is -0.03336014.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Editas Medicine Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Editas Medicine Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Editas Medicine Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Editas Medicine Inc Daily Moving Average Convergence/Divergence (MACD) ChartEditas Medicine Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Editas Medicine Inc. The current adx is 30.36.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Editas Medicine Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Editas Medicine Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Editas Medicine Inc. The current sar is 1.96397288.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Editas Medicine Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Editas Medicine Inc. The current rsi is 42.24. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Editas Medicine Inc Daily Relative Strength Index (RSI) ChartEditas Medicine Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Editas Medicine Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Editas Medicine Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Editas Medicine Inc Daily Stochastic Oscillator ChartEditas Medicine Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Editas Medicine Inc. The current cci is -112.07948745.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Editas Medicine Inc Daily Commodity Channel Index (CCI) ChartEditas Medicine Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Editas Medicine Inc. The current cmo is -24.47605776.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Editas Medicine Inc Daily Chande Momentum Oscillator (CMO) ChartEditas Medicine Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Editas Medicine Inc. The current willr is -85.02377179.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Editas Medicine Inc Daily Williams %R ChartEditas Medicine Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Editas Medicine Inc.

Editas Medicine Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Editas Medicine Inc. The current atr is 0.13459624.

Editas Medicine Inc Daily Average True Range (ATR) ChartEditas Medicine Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Editas Medicine Inc. The current obv is -7,695.

Editas Medicine Inc Daily On-Balance Volume (OBV) ChartEditas Medicine Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Editas Medicine Inc. The current mfi is 7.22669666.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Editas Medicine Inc Daily Money Flow Index (MFI) ChartEditas Medicine Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Editas Medicine Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Editas Medicine Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Editas Medicine Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.240
Ma 20Greater thanMa 501.657
Ma 50Greater thanMa 1001.402
Ma 100Greater thanMa 2001.813
OpenGreater thanClose1.234
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Editas Medicine Inc with someone you think should read this too:
  • Are you bullish or bearish on Editas Medicine Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Editas Medicine Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Editas Medicine Inc

I send you an email if I find something interesting about Editas Medicine Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Editas Medicine Inc.

Receive notifications about Editas Medicine Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.